Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

Indoco Remedies Ltd., a fully integrated, research-oriented pharmaceutical company, announced final approval of the company’s Abbreviated New Drug Application (ANDA) for rivaroxaban tablets USP, 2.5 ...

LOS ANGELES, CA—Another real-world study has suggested that there may be differences among the non-vitamin K antagonist oral anticoagulants (NOACs) in terms of the risk of major bleeding. Among ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BARCELONA -- ...

November 25, 2009 (New Orleans, Louisiana) — Early results from an extension study testing the effectiveness of rivaroxaban (Xarelto, Johnson & Johnson) in the setting of secondary prevention has ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. • Rivaroxaban (COVIXABAN) is indicated for ...

A short IV bolus of a ‘decoy’ molecule almost immediately reverses rivaroxaban anticoagulation, according to a proof-of-concept study. The new agent relieves some concern about management of patients ...

Participants were randomized and administered monthly injections of 150 mg abelacimab, 90 mg abelacimab, or standard dosing of rivaroxaban (20 mg or 15 mg in dose reduced patients). The team found ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Extended therapeutic-level prophylactic anticoagulation with ...

Grenoble, France - With the long-awaited advents of rivaroxaban (Xarelto, Bayer/Johnson & Johnson), apixaban (Eliquis, Pfizer/Bristol-Myers Squibb), and dabigatran (Pradaxa, Boehringer Ingelheim) as ...